Effect of the rs168924 single-nucleotide polymorphism in the SLC6A2 catecholamine transporter gene on blood pressure in Caucasians

J Clin Hypertens (Greenwich). 2012 May;14(5):293-8. doi: 10.1111/j.1751-7176.2012.00618.x. Epub 2012 Apr 9.

Abstract

The NG_016969.1:g.5003A>G promoter polymorphism (rs168924) in the SLC6A2 norepinephrine transporter gene was found to be predictive of the hypertensive status in a Japanese population, but no data are available for Caucasians. Genotyping for rs168924 was performed in 282 young men with normal blood pressure (BP), grade 1 or 2 hypertension. In addition to casual BP, 24-hour ABPM and echocardiography were performed. Multiple regression analysis revealed a significant association of rs168924 genotype with diagnosis of hypertension (P=.044), casual systolic BP (SBP) levels (P=.028), and daytime ambulatory SBP (P=.02). The finding that rs168924 was also significantly associated with diastolic posterior wall thickness (P=.041), an echocardiographic index of hypertensive cardiac target organ damage, further supports the notion that the rs168924 SNP in SLC6A2 in fact might influence BP. Unlike previous findings in a Japanese population, in our Caucasian study cohort the presence of the minor rs168924 G allele was associated with lower prevalence of hypertension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Pressure / genetics*
  • Case-Control Studies
  • Cohort Studies
  • Echocardiography
  • Genotype
  • Humans
  • Hypertension / epidemiology
  • Hypertension / ethnology*
  • Hypertension / genetics*
  • Linkage Disequilibrium / genetics
  • Male
  • Norepinephrine Plasma Membrane Transport Proteins / genetics*
  • Phenotype
  • Polymorphism, Single Nucleotide / genetics*
  • Prevalence
  • Regression Analysis
  • White People / ethnology*
  • White People / genetics*

Substances

  • Norepinephrine Plasma Membrane Transport Proteins
  • SLC6A2 protein, human